• PORTFOLIO
  • ABOUT US
  • TEAM
  • CHALLENGE NETWORK
  • INSIGHTS
  • PRESS
  • CONTACT
From Molecule to Medicine: Paul Weiss on Centanafadine’s Journey to FDA Approval

From Molecule to Medicine: Paul Weiss on Centanafadine’s Journey to FDA Approval

by Clarevia Team | Oct 6, 2026 | Perspectives

Most drug candidates never make it all the way to patients. For early-stage healthcare investors, seeing a therapeutic advance from an early scientific idea through clinical development, acquisition, FDA approval, and ultimately toward commercialization is especially...

Follow Us

  • Follow

Quick Links

Home

Portfolio

About Us
Team
Challenge Network
Insights
Press
Contact

Join the Clarevia Community!

indicates required
Copyright © 2026. Clarevia. All Rights Reserved.